Philippe Marchand
Analyste en capital-investissement chez Investissement Québec
Profil
Philippe Marchand is currently an Analyst at Investissement Québec since 2019.
Prior to this, he held positions as Principal at Edwards Lifesciences Corp., CryoCath Technologies, Inc., and Senior Engineer-Research & Development at ev3, Inc. He also worked as Manager-Research & Development at Sequent Medical, Inc. Marchand received his undergraduate and graduate degrees from McGill University.
Postes actifs de Philippe Marchand
| Sociétés | Poste | Début |
|---|---|---|
Investissement Québec
 Investissement Québec Investment ManagersFinance Investissement Québec (Investissement Quebec) is a Private Equity/Venture Capital firm, a subsidiary of Province of Québec founded in 1998. The firm is headquartered in Montréal. | Analyste en capital-investissement | 07/01/2019 |
Anciens postes connus de Philippe Marchand
| Sociétés | Poste | Fin |
|---|---|---|
ev3, Inc.
 ev3, Inc. Medical SpecialtiesHealth Technology ev3, Inc. is a provider for specialists treating a range of vascular diseases and disorders. ev3 is committed to the peripheral vascular and neurovascular markets offering a portfolio of treatment options, including interventional technologies used such as plaque excision systems, PTA balloons, stents, embolic protection, thrombectomy, embolization coils, liquid embolics, occlusion balloons and procedural support. | Directeur Technique/Scientifique/R&D | - |
| EDWARDS LIFESCIENCES CORPORATION | Corporate Officer/Principal | - |
CryoCath Technologies, Inc.
 CryoCath Technologies, Inc. Medical SpecialtiesHealth Technology CryoCath Technologies, Inc. manufactures medical equipment. The company was founded by Normand Balthazard and Andre L. Lamotte in 1994 and is headquartered in Montreal, QC. | Corporate Officer/Principal | - |
Sequent Medical, Inc.
 Sequent Medical, Inc. Medical SpecialtiesHealth Technology Sequent Medical, Inc. operates as a medical device company. It develops catheter-based neurovascular technologies. The company was founded by Robert F. Rosenbluth and Brian J. Cox in August 2007 and is headquartered in Aliso Viejo, CA. | Directeur Technique/Scientifique/R&D | - |
Formation de Philippe Marchand
| McGill University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| EDWARDS LIFESCIENCES CORPORATION | Health Technology |
| Entreprise privées | 4 |
|---|---|
Sequent Medical, Inc.
Sequent Medical, Inc. Medical SpecialtiesHealth Technology Sequent Medical, Inc. operates as a medical device company. It develops catheter-based neurovascular technologies. The company was founded by Robert F. Rosenbluth and Brian J. Cox in August 2007 and is headquartered in Aliso Viejo, CA. | Health Technology |
CryoCath Technologies, Inc.
CryoCath Technologies, Inc. Medical SpecialtiesHealth Technology CryoCath Technologies, Inc. manufactures medical equipment. The company was founded by Normand Balthazard and Andre L. Lamotte in 1994 and is headquartered in Montreal, QC. | Health Technology |
ev3, Inc.
ev3, Inc. Medical SpecialtiesHealth Technology ev3, Inc. is a provider for specialists treating a range of vascular diseases and disorders. ev3 is committed to the peripheral vascular and neurovascular markets offering a portfolio of treatment options, including interventional technologies used such as plaque excision systems, PTA balloons, stents, embolic protection, thrombectomy, embolization coils, liquid embolics, occlusion balloons and procedural support. | Health Technology |
Investissement Québec
Investissement Québec Investment ManagersFinance Investissement Québec (Investissement Quebec) is a Private Equity/Venture Capital firm, a subsidiary of Province of Québec founded in 1998. The firm is headquartered in Montréal. | Finance |